Drugplain

Norgesic 385 mg/1

Orphenadrine Citrate, Aspirin and Caffeine · TABLET · Galt Pharmaceuticals, LLC

No Recall History
Plain English

Norgesic is a tablet containing orphenadrine citrate, aspirin and caffeine at 385 mg/1, taken oral. Manufactured by Galt Pharmaceuticals, LLC.

Key Facts

Brand Name
Norgesic
Generic Name
Orphenadrine Citrate, Aspirin and Caffeine
NDC Code (Product)
61825-305
Manufacturer
Galt Pharmaceuticals, LLC
Strength
385 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
ANDA075141
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
05/16/2022

Recall History

No Recall History

Frequently Asked Questions

What is Norgesic used for?

Norgesic contains Orphenadrine Citrate, Aspirin and Caffeine. It is a tablet taken oral. Consult your doctor for specific uses.

Is Norgesic a controlled substance?

Norgesic is not classified as a controlled substance by the DEA.

What is the generic name for Norgesic?

The generic name for Norgesic is Orphenadrine Citrate, Aspirin and Caffeine. There are 4 other brand versions of Orphenadrine Citrate, Aspirin and Caffeine.

What is the NDC code for Norgesic 385 mg/1?

The NDC (National Drug Code) for Norgesic 385 mg/1 is 61825-305, listed by Galt Pharmaceuticals, LLC.

Product NDC

61825-305

Package NDC

61825-305-60

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)